Location History:
- Rio de Janeiro, BR (2014)
- Rio de Janerio, BR (2016)
Company Filing History:
Years Active: 2014-2016
Title: Robson De Queiroz Monteiro: Innovator in Cancer Treatment
Introduction
Robson De Queiroz Monteiro is a notable inventor based in Rio de Janeiro, Brazil. He has made significant contributions to the field of medical research, particularly in the treatment of cancer. With a total of 2 patents, his work focuses on innovative methods for inhibiting angiogenesis, which is crucial in cancer progression.
Latest Patents
Monteiro's latest patents include the use of ixolaris, a tissue factor inhibitor, for inhibiting angiogenesis. This invention provides methods for the treatment of tissue factor (TF) mediated or associated diseases, such as cancer, by administering at least an active fragment of an Ixolaris polypeptide to a subject. The invention also includes the identification of a subject in need of such treatment and monitoring for amelioration of at least one sign or symptom of the disease. Additionally, the invention features kits designed for this purpose. Another patent focuses on the use of ixolaris for the treatment of cancer, reiterating the importance of this polypeptide in combating TF mediated diseases.
Career Highlights
Monteiro is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute to groundbreaking research in the medical field.
Collaborations
Some of his notable coworkers include Jose Marcos C Ribeiro and Ivo M B Francischetti, who have collaborated with him on various research projects.
Conclusion
Robson De Queiroz Monteiro's innovative work in cancer treatment through the use of ixolaris showcases his dedication to advancing medical science. His contributions are vital in the ongoing fight against cancer and highlight the importance of research in developing effective treatments.